Topics covered:
1) 0:00 Announcements
2) 0:30 Market Commentary and Index Review (Nasdaq Composite, S&P 500, and Russell 2000)
3) 7:20 FOCUS LIST: NVDA, MSFT, META, NOW, UBER, LLY, NVO, WING, CRWD, ISRG, ARM, DELL
4) 15:05 Stock Review – Software: IGV (ETF), CDNS, SNPS, CRM
5) 16:15 Stock Review – Semiconductors: SMH (ETF), AVGO, LRCX, KLAC, AMD, MRVL, ACMR
6) 18:20 Stock Review – Biotech/Medical Products: XBI (ETF), AQST, CYTK, MGNX, VKTX, ABOS, INZY, RXST, TMDX, MEDP, SWAV, NTRA
7) 24:25 Stock Review – Watch List/General Ideas/Commentary: SMCI, NFLX, DECK, SHAK, CMG, TXRH, FWRG, CAVA, VRT, CLS, CAMT, PSTG, NTAP, CELH
8) 27:50 Conclusion/Summary

Market Summary:
Here are the concepts I discussed in the two 2024 Preview Videos: 1) I am bullish over the next 6-12 months because of all the technical strength we saw from November through January. The institutions aggressively came back into the markets because of the new bull market powered by AI, and they are anticipating the Fed lowering rates this year. 2) Does that mean we will go straight up with no pullbacks? Of course not! That’s why I’ve also discussed the theme of “using the 21-day EMA as your guide.” 3) Stay focused on the best growth stocks/ETFs out there. 4) Get strong entry points and manage your trades based on your timeframe and overall investment plan. If you don’t have a plan, please continue to finetune it and work on one that fits your situation. 5) Manage risk and stick to your stops. Just because it’s a bull market doesn’t mean everything is going to work out.

The theme of this video is be open-minded, remain patient, and stay disciplined. Positives: 1) We’re still in an uptrend. 2) The Nasdaq Composite and S&P 500 continue to show resiliency and hold above their respective 21-day EMAs. 3) Many leading growth stocks continue to hold up well and I review them in this video. Negatives: 1) Distribution days on the Nasdaq Comp are adding up (5 in the past two weeks). 2) The end of the quarter tends to see added volatility and profit-taking. 3) We’ve haven’t visited the 50-day in a while. Conclusion: As I’ve mentioned in recent videos, when there’s a mixed picture, lean defensive. For me, defensive means not looking to buy new positions, if I buy anything new or add to existing positions, I do so with LIGHT positions, and making sure to stick to a loss-cutting discipline if anything turns against me.

I’m very grateful that many new members joined recently and I realize that you are looking for ideas, but please keep in mind that I prefer to remain patient until we get a clearer picture. I want to see how the market acts around key support levels, and I would also like to wait for the recent selling to slow down. One goal of this product is to keep you on the right side of the market. Longer-term, we’re still in a strong trend, but over the near-term, the winds are swirling and I would like to wait until we get through this seasonally weak period. If you have any questions, you can ask them during the next LIVE webinar which will be a week from Sunday on March 24th at 7PM EST. Thank you and enjoy the remainder of your weekend.

Unusual Option Activity:
3/15/24 S&P 500 ETF (SPY) large buys of 4400 April 30th $519 puts at $11.55 to $12.02
3/15/24 Tesla (TSLA) 2000 November $180 calls sold to open 22.20
3/15/24 Netflix (NFLX) 350 July $690 calls bought $29 offer
3/15/24 eBay (EBAY) with 4700 January 2026 $50 calls bought $10.50
3/15/24 MGM Resorts (MGM) 1480 May $44 puts selling to open $2.58
3/15/24 Marathon Petro (MPC) 325 December $230 calls bought $9.55
3/15/24 Phillips 66 (PSX) seeing 870 May $160 puts sell to open at $7.60
3/15/24 Shift4 Payments (FOUR) April $85 call buyers here 2200X with M&A talks $2.95 to $3
3/15/24 Shift4 Payments (FOUR) also 2000 April $72.5 calls bought $4 to $4.30
3/15/24 Pfizer (PFE) opening sales of 12,400 April 26th $26 puts at $0.23
3/15/24 Cytokinetics (CYTK) opening sale 6000 April $60 puts 2.95 as March 65 adjust
3/15/24 Cytokinetics (CYTK) spread selling 1500 Jan $70 puts to buy $70/$90 call spreads
3/15/24 Viking Therapeutics (VKTX) seeing 1500 April $60/$40 put spreads bought $8.20
3/15/24 Madrigal Pharma (MDGL) 275 April $340 calls bought $15.10 offer
3/15/24 Aquestive Therapeutics (AQST) unusual buy 1000 August $10 calls for $1.35
AQST is a $400M market cap Biotech trading 18X Cash and 3X FY27 forecasted Sales with 5.7% of the float short. AQST recently announced positive top-line results from its pivotal pharmacokinetic trial for Anaphylm, meeting all primary and secondary endpoints. Libervant’s potential April FDA approval and Anaphylm’s anticipated NDA submission by year-end should make for an eventful year.
3/15/24 AstraZeneca (AZN) opening sale of 4940 April 26th $62 puts at $0.50, captures earnings 4/25
3/15/24 Palantir (PLTR) buyer 3500 April 12th (W) $25.50 calls 0.82 offer
3/15/24 Apple (AAPL) buyers coming for 40,000 August $195 calls $3.25 to $3.35
3/15/24 Microsoft (MSFT) large buyer of 8500 August $480 calls at $9.15 as the $460 calls adjust up from early year buys
3/15/24 Super Micro (SMCI) with 450 May $1000 puts bought for $5M
3/15/24 Google (GOOGL) buyer of 3000 April 26th $145 calls at $4.45
3/15/24 Micron (MU) opening seller of 1800 May $87.50 puts at $3.95
3/15/24 Vertiv (VRT) 2190 July 105 calls sell to open 2.80
3/14/24 S&P 500 ETF (SPY) with 3000 May 31st $497 puts selling to open at $5.19
3/14/24 Treasury ETF (TLT) 1300 February 2025 $93 puts sold to open for 4.80
3/14/24 Utility ETF (XLU) 2000 Jan. 2026 $61 puts sell to open 4.15
3/14/24 Lululemon (LULU) reports next week and seeing 1000 April $550 calls sell to open $5.26
3/14/24 Lowes (LOW) buyer 2000 April $240 puts $3.70 as March adjust
3/14/24 Home Depot (HD) with 1500 April $370 puts bought $5.65 to $5.75
3/14/24 Home Depot (HD) also buyers 600 May $370 puts $9.80
3/14/24 Wynn Resorts (WYNN) with 600 June 2025 $145 calls bought 4.05 offer
3/14/24 Occidental (OXY) 300 July 67.5 puts sell to open $6
3/14/24 Exxon (XOM) 2000 Jan 2026 $120 calls bought up to $10.60 on some April call adjustments
3/14/24 Diamondback Energy (FANG) buyer 1500 July $220 calls 2.45 to 2.49
3/14/24 Eli Lilly (LLY) buyer of 250 July $700 calls at $95.00
3/14/24 Crispr Therapeutics (CRSP) buyer of 1000 April $60 ITM calls at $14.40 as March adjust
3/14/24 DexCom (DXCM) with 3390 April 26th (W) 110 puts sold to open 1.08
3/14/24 Gilead Sciences (GILD) seeing 3000 Jan 2026 $105 calls buying at $2 to $2.15
3/14/24 Carrier (CARR) buyer of 2067 June $52.50 calls at $6.70, adjusting March and also sells the June $45 puts at 0.33
3/14/24 Amazon (AMZN) large buy 3000 June 2025 $200 calls $20.27 as 1500 $125 calls adjust
3/14/24 Microsoft (MSFT) large buys 5000 May $430 calls $16.10 to $16.50
3/14/24 Palo Alto (PANW) buyer of 600 Jan $320 calls at $34.30
3/14/24 Lam Research (LRCX) buyers of 250 April $930 calls at $47
3/14/24 Celestica (CLS) opening sale 1000 July $50 calls for 3.90
3/14/24 Arista Networks (ANET) bull flow again with 900 April $310 calls buying 5.10 to 5.30
3/14/24 Advanced Micro (AMD) seeing 2500 August $270/$310 call spreads buy to open